Skip to main content
Fig. 1 | Molecular Cancer

Fig. 1

From: SLAMF receptors: key regulators of tumor progression and emerging targets for cancer immunotherapy

Fig. 1

The molecular structures of SLAMF receptors and their respective initial discoveries. Abbreviation: Ig, immunoglobulin; NK, natural killer; ITSM, immunoreceptor tyrosine-based switch motif; SH2, Src homology 2; EBV, Epstein-Barr virus; SLAMF, signaling lymphocytic activation molecule family; IgV, immunoglobulin variable; IgC2, immunoglobulin constant 2; CD, cluster of differentiation. The figure is created with BioRender.com

Back to article page